StonvexLoading…
StonvexStonvexStonvexCore line items from OPCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $1.45B | $5.65B | $4.18B | $2.75B | $5.00B |
Operating Income | Not available | $337.91M | $246.41M | $161.90M | $321.83M |
Net Income | Not available | $207.59M | $149.08M | $50.52M | $211.82M |
EPS (Diluted) | $0.43 | $1.27 | $0.91 | $0.59 | $1.23 |
Total Assets | Not available | $3.46B | $3.48B | $3.38B | $3.42B |
Total Liabilities | Not available | $2.13B | $2.12B | $2.02B | $2.02B |
Cash & Equivalents | Not available | $232.62M | $309.82M | $198.82M | $412.56M |
Free Cash Flow OCF − CapEx | Not available | $217.14M | $194.90M | $64.65M | $287.79M |
Shares Outstanding | Not available | 156.86M | 160.11M | 162.29M | 166.26M |